Ômega-3: o que existe de concreto? - Nutritotal

Montori VM, Farmer A, Wollan PC, Dinneen SF. Fish oil supplementation intype 2 diabetes: a quantitative systematic review. Diabetes Care.2000;23(9):1407-15.Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS. Dietary fish and n-3 fattyacid intake and cardiac electrocardiographic parameters in humans. J Am CollCardiol. 2006;48(3):478-84.Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietarysupplementation with fish oil rich in omega-3 polyunsaturated fatty acids inchildren with bronchial asthma. Eur Respir J. 2000;16(5):861-5.Nakamura N, Hamazaki T, Ohta M, et al. Joint effects of HMG-CoA reductaseinhibitors and eicosapentaenoic acids on serum lipid profile and plasma fattyacid concentrations in patients with hyperlipidemia. Int J Clin Lab Res.1999;29(1):22-5.Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H. Effect of omega-3fatty acids and simvastatin on hemostatic risk factors and postprandialhyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb VascBiol. 2000;20(1):259-65.Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomisedclinical trials of fish oil supplementation in high risk pregnancies. Fish Oil TrialsIn Pregnancy (FOTIP) Team. BJOG. 2000;107(3):382-95Olsen SF, Sørensen JD, Secher NJ, et al. Randomised controlled trial of effectof fish-oil supplementation on pregnancy duration. Lancet.1992;339(8800):1003-7Olsen SF, Hansen HS, Sommer S, et al. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islandsand Denmark. Am J Obstet Gynecol. 1991;164(5 Pt 1):1203-9.Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomiseddouble blind placebo controlled trial of fish oil in high risk pregnancy. Br JObstet Gynaecol. 1995;102(2):95-100.Oostenbrug GS, Mensink RP, Hardeman MR, De Vries T, Brouns F, HornstraG. Exercise performance, red blood cell deformability, and lipid peroxidation:effects of fish oil and vitamin E. J Appl Physiol. 1997;83(3):746-52.Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alphaactivation modulates cellular redox status, represses nuclear factor-kappaBsignaling, and reduces inflammatory cytokine production in aging. J Biol Chem.1998;273(49):32833-41.Raastad T, Hostmark AT, Stromme SB. Omega-3 fatty acid supplementationdoes not improve maximal aerobic power, anaerobic threshold and running36